It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence.

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

Dave Coulier, best known for his role as Joey Gladstone on the beloved sitcom Full House, has been declared cancer-free just ...

An inquest into the death of a former England footballer has considered whether his career could have been a factor in his ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

The reactions to the intracutaneous injections of five antigens and histamine were studied in 114 persons, of whom 33 were patients with Hodgkin's disease, 64 were controls and the remainder had ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...